The Asia-Pacific medical thawing system market is expected to record a CAGR of 8.80% during the forecast period, 2022-2030, and is set to garner a revenue of $84.02 million by 2030.

In Asia, lung cancer, chronic obstructive pulmonary diseases (COPDs), diabetes mellitus (DM), and cardiovascular diseases are the leading causes of death. These diseases require timely intervention in the form of blood and plasma donation, which further contributes to the region’s thawing system demands.

To know more about this report, request a free sample copy

In addition, countries like India witness high numbers of road accident deaths. For instance, according to government sources, a total of 449,002 accidents took place in 2019, resulting in 451,361 injuries and 151,113 deaths in the country. The medical thawing system is crucial for blood transfusion logistics, thereby offering growth opportunities.

The Asia-Pacific medical thawing system market growth evaluation includes the assessment of India, South Korea, Japan, China, Singapore, Taiwan, Australia & New Zealand, Indonesia, and Rest of Asia-Pacific. China has high demographics. Also, it has a lucrative economy, enabling investments in medical equipment manufacturing and exports. Additionally, according to government sources, there were 33,000 hospitals in 2019. Besides, as per the country’s National Health Commission (NHC), China witnessed a large number of blood donations recently despite the COVID-19 impact.

Further, according to NHC, with the Blood Donation Law of 1998 in place, blood donations have increased significantly. The law also led to the establishment of 452 blood supply stations and built a multi-layer service network encompassing blood depositories, stations, and supply centers. Such aspects, along with the dense population, blood donations, hospital coverage, manufacturing capabilities, and capital investments, propel China’s market growth.

In South Korea, almost 2.6 million donated blood in 2020. Also, the country’s medical centers, clinics, and hospitals have sperm bank facilities. In addition, the pharma market was valued at $20.9 billion, as per the Korea Health Industry Development Institute in 2020. Since pharma companies are key buyers of thawing systems, the country offers huge scope for the market analyzed. Moreover, the government had established measures at the end of 2020 to tackle declining birth rates. These include encouraging IVF procedures, sperm donation, and embryo freezing. Such factors make South Korea a conducive market for blood thawing systems.

The Asia-Pacific medical thawing system market segmentation includes end-user and sample type. The end-user segment entails pharmaceutical & biotech companies, tissue banks, hospitals, blood banks, and other end-users.

In pharma companies, thawing systems undertake the role of unfreezing the drugs without damaging their chemical properties. Biotech companies thaw biological samples for cell biology research. Whereas pharma companies freeze bulk drug substances during or after production to minimize the biological/chemical degradation, thereby preserving the product’s stability. At the same time, freezing extends product shelf-life and restricts microbial growth. Further, it aids in preventing contamination by reducing the exposure of the drug substance to the walls of the storage container.

Some of the prominent companies in the Asia-Pacific medical thawing system market include Terumo Corporation, Sartorius AG, Single Use Support GmbH, Thermo Fisher Scientific Inc, etc.

Terumo Corporation develops, manufactures, and distributes medical devices and services globally. The company’s blood and cell technologies segment offers centrifugal apheresis systems, pathogen reduction technology, automated blood processing systems, etc. It operates in North America, Asia, the Middle East & Africa, and Latin America, with headquarters in Tokyo, Japan.

One of its key products includes a plasma bath (PB 100) that offers the optimum thawing mechanism for plasma with a capacity of up to 12p plasma bags in a single thawing cycle.

Report Synopsis:

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.